JPMorgan Chase & Co. Purchases 22,092 Shares of Anterix Inc. (NASDAQ:ATEX)

JPMorgan Chase & Co. lifted its position in shares of Anterix Inc. (NASDAQ:ATEXFree Report) by 188.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,832 shares of the company’s stock after acquiring an additional 22,092 shares during the period. JPMorgan Chase & Co.’s holdings in Anterix were worth $1,274,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in ATEX. nVerses Capital LLC bought a new position in Anterix in the third quarter valued at about $45,000. Meeder Asset Management Inc. acquired a new position in shares of Anterix in the third quarter valued at approximately $58,000. Point72 Asia Singapore Pte. Ltd. bought a new position in Anterix in the 2nd quarter valued at approximately $92,000. Point72 DIFC Ltd boosted its position in Anterix by 440.8% during the 3rd quarter. Point72 DIFC Ltd now owns 2,639 shares of the company’s stock worth $99,000 after buying an additional 2,151 shares during the period. Finally, The Manufacturers Life Insurance Company bought a new stake in Anterix during the 2nd quarter worth approximately $203,000. Institutional investors and hedge funds own 87.67% of the company’s stock.

Analyst Ratings Changes

Separately, Craig Hallum upgraded shares of Anterix to a “strong-buy” rating in a report on Wednesday, October 9th.

Get Our Latest Research Report on ATEX

Anterix Price Performance

Shares of NASDAQ:ATEX opened at $29.81 on Friday. The business’s 50-day moving average is $31.63 and its 200-day moving average is $34.94. Anterix Inc. has a 1 year low of $27.37 and a 1 year high of $42.41. The company has a market capitalization of $555.06 million, a price-to-earnings ratio of -14.76 and a beta of 0.87.

Insider Buying and Selling at Anterix

In related news, Director Mark Fleischhauer purchased 3,500 shares of the firm’s stock in a transaction that occurred on Thursday, December 5th. The stock was acquired at an average price of $34.19 per share, for a total transaction of $119,665.00. Following the completion of the acquisition, the director now owns 3,500 shares of the company’s stock, valued at $119,665. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Leslie B. Daniels purchased 2,000 shares of the stock in a transaction that occurred on Wednesday, November 20th. The stock was bought at an average cost of $32.75 per share, with a total value of $65,500.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at $65,500. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 45.61% of the company’s stock.

Anterix Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

See Also

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.